A Case of Iliopsoas Hematoma in a Patient on Acenocoumarol

Published on: June 2025

Indian Journal of Pharmacy Practice, 2025; 18(4):451-454.

Case Report| doi: 10.5530/ijopp.20250281

Authors and affiliation (s):

Yashaswini Parunandi, Suvarchala Shenkeshi, Samatha Tanniru, Sandeep Goud Mitta*

Department of Pharmacy Practice, Vaagdevi Pharmacy College, Bollikunta, Warangal, Telangana, INDIA.

ABSTRACT

The iliopsoas hematoma is a rare condition that can result from various factors, such as trauma, anticoagulant use, iatrogenic injury during lumbar procedures, and bleeding disorders. Bleeding complications are expected to become more common with the increasing use of anticoagulants. We present the case of a 53-year-old female with a known history of Chronic Rheumatic Heart Disease (CRHD) and Mitral valve Stenosis (MS), who had previously undergone Mitral Valve Repair (MVR). Since then, she had been on oral Acenocoumarol therapy. Over time, her prothrombin time and International Normalized Ratio (INR) gradually became deranged. The patient’s condition stabilized after reducing the dose of Acenocoumarol.

Keywords: Acenocoumarol, Anticoagulants, Iliopsoas Hematoma, International Normalized Ratio.